JPMorgan Chase & Co. (0Q1F)
London Stock Exchange · UK · prices in USD · close of 27 Oct 2026
Key indicators
| Last close | USD 336.40 |
|---|---|
| 52-week range | 279.08 – 371.00 |
| Return, 1 month / 3 months | −1.0% / −4.5% |
| Return, 1 year / 3 years | +13.0% / +160.9% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 50 |
| Volatility (1 year) | 21.3% |
| Worst drawdown (1 year) | -15.7% |
| Average daily value traded | 12.36M USD |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
JPMorgan Chase & Co. is a bank holding company based in New York that serves consumers, small businesses, corporations and institutional clients. Its consumer arm offers checking and savings accounts, credit cards, mortgages and auto loans through branches and digital channels. The firm also provides investment banking, lending, treasury services and market-making to companies and investors, and manages money and wealth for individuals and institutions.
The shares are listed on the London Stock Exchange in UK under the code 0Q1F, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
JPMorgan Chase & Co. (0Q1F) trades on the London Stock Exchange in UK. It last closed at USD 336.40 on 27 October 2026.
Its price-based Market X-Ray is 68 out of 100 (a fair price profile), ranking 701 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.0% and over the last three months it fell 4.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.0% | ||
| From 52-week high | -7.8% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.5% | ||
| 6-month return | 9.3% | ||
| 12-month return, skipping the last month | 14.2% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.7% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 12.36M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 37 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.2% |
|---|---|
| 1 month | −1.0% |
| 3 months | −4.5% |
| 6 months | +9.3% |
| 1 year | +13.0% |
| 3 years | +160.9% |
| 5 years | +125.6% |
Signals
| 50-day / 200-day average | 342.88 / 320.31 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 7.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Oct 2026 | USD 1.6500 |
| 6 Jul 2026 | USD 1.5000 |
| 6 Apr 2026 | USD 1.5000 |
| 6 Jan 2026 | USD 1.5000 |
| 6 Oct 2025 | USD 1.5000 |
| 2 Jul 2025 | USD 1.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.